BioKeralty Research Institute is part of Keralty group’s research, development and innovation (R&D&I) division. Following the Keralty’s health model principles, BioKeralty drives and coordinates research and development projects in several health areas. The main research areas are: chronic diseases, regenerative medicine, cancer, personalized medicine or digital health, as well as health value, social care and community care.
Thought its participation in several partnerships, R&D&I projects and related calls, Keralty group works in the implementation of attention models, management models and health technologies and tools. In this way, Keralty aims to create competitive advantage that will allow the group share and add value to its patients and health professionals.
For three intense days, Seville was the setting for the 3rd Plenary Meeting of the European CARAMEL project, a key event that brought together more than 30 health professionals, researchers and technology providers. The event, organised by the Andalusian Health Service (SAS)…
The European consortium IN-ARMOR, of which Biokeralty is a partner, has recently published a review article in the journal Blood Reviews (Elsevier) entitled “Host-directed therapies modulating innate immunity against infection in hematologic malignancies”. This work, co-authored by researchers from the University of…
For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.
Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.
Primary care
Cancer
Chronic and neurodegenerative
Infectious diseases
E-health
Genomics and personalized
Regenerative medicine
Nanotechnology
Education
Community
Social
Health value